Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Anti-Cancer Drugs|January 1, 1996
Absence of hepatic enzyme induction in prostate cancer patients receiving 'Casodex' (bicalutamide)A Kaisary, P Klarskov, D McKillopPharmacogenetics|June 1, 1992
The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancerC M Fleming, A Kaisary, G R Wilkinson, et al.Microsurgery|April 5, 2001
Delayed penile replantation after prolonged warm ischemiaA Mosahebi, M Butterworth, R Knight, et al.Cancer Research|October 15, 1987
Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factorsA Kaisary, P Smith, E Jaczq, et al.Pharmacogenetics|August 1, 1994
Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancerC M Fleming, R Persad, A Kaisary, et al.Pageof 1